In the ND group the GMT of IgA responses in ALS was bimodal and increased again at day 84 (GMT of 2.0 fold increase from day 28 to 84, p = 0.038) (Fig 7C) similar to the dose dependent response (Fig 7C). The gene discussed is CD79A; the disease is amyotrophic lateral sclerosis.